An Open-Label, Multicenter Study of Outpatient Capecitabine Monotherapy in 631 Patients with Pretreated Advanced Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|72|1-2|51-57

ISSN： 0030-2414

Source： Oncology, Vol.72, Iss.1-2, 2007-11, pp. : 51-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sequential erlotinib with gemcitabine in NSCLC

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 1, 2015-03 ,pp. : 4-14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Study of Adjuvant Capecitabine Monotherapy in Chinese Elderly Patients (Aged 55–70) with Stage IIa Breast Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 8-9, 2010-07 ,pp. : 433-436

Karger

Access to resources Recommend Favorite

Oral Capecitabine in Gemcitabine-Pretreated Patients with Advanced Pancreatic Cancer

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 221-227

Karger

Access to resources Recommend Favorite

A Multicenter Phase II Study of Docetaxel in Combination with Gefitinib in Gemcitabine-Pretreated Patients with Advanced/Metastatic Pancreatic Cancer

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 159-163

Karger

Access to resources Recommend Favorite

Gemcitabine plus Irinotecan in Breast Cancer Patients Pretreated with Taxanes and Anthracyclines: A Multicenter Phase II Study

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 477-478

Karger

Access to resources Recommend Favorite